Clinical trial
Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin…
NCT00472381 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00472381 |
|---|---|
| Title | Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke |
| Official title | Assessment of Continuous Intravenous Insulin Protocol Versus Subcutaneous Insulin in Acute Ischemic Stroke |
| Acronym | INSULINFARCT |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Acute Stroke, Acute Cerebral Ischemia |
| Intervention type | Drug |
| Interventions | Insulin |
| Enrollment | 180 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | May 11, 2007 |
| Last update posted | Jun 5, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: